Home › Trial NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Trial IDNCT06079671
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorAstraZeneca
- Enrollment800
- Start date2023-09-22
- ConditionsLocally Advanced Cervical Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.